• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-氮杂胞苷(5azadC)处理可上调miR-375水平并抑制HPV16 E6表达。

5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression.

作者信息

Morel Adrien, Baguet Aurélie, Perrard Jérôme, Demeret Caroline, Jacquin Elise, Guenat David, Mougin Christiane, Prétet Jean-Luc

机构信息

EA3181, Université Bourgogne Franche-Comté, LabEx LipSTIC ANR-11-LABX-0021, Besançon, France.

Département de Virologie, Institut Pasteur, Unité de Génétique Moléculaire des Virus à ARN, CNRS UMR 3569, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

出版信息

Oncotarget. 2017 Jul 11;8(28):46163-46176. doi: 10.18632/oncotarget.17575.

DOI:10.18632/oncotarget.17575
PMID:28521287
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5542257/
Abstract

High-risk human papillomaviruses are the etiological agents of cervical cancer and HPV16 is the most oncogenic genotype. Immortalization and transformation of infected cells requires the overexpression of the two viral oncoproteins E6 and E7 following HPV DNA integration into the host cell genome. Integration often leads to the loss of the E2 open reading frame and the corresponding protein can no longer act as a transcriptional repressor on p97 promoter. Recently, it has been proposed that long control region methylation also contributes to the regulation of E6/E7 expression.To determine which epigenetic mechanism is involved in HPV16 early gene regulation, 5-aza-2'-deoxycytidine was used to demethylate Ca Ski and SiHa cell DNA. Decreased expression of E6 mRNA and protein levels was observed in both cell lines in an E2-independent manner. E6 repression was accompanied by neither a modification of the main cellular transcription factor expression involved in long control region regulation, nor by a modification of the E6 mRNA splicing pattern. In contrast, a pronounced upregulation of miR-375, known to destabilize HPV16 early viral mRNA, was observed. Finally, the use of miR-375 inhibitor definitively proved the involvement of miR-375 in E6 repression. These results highlight that cellular DNA methylation modulates HPV16 early gene expression and support a role for epigenetic events in high-risk HPV associated-carcinogenesis.

摘要

高危型人乳头瘤病毒是宫颈癌的病原体,而HPV16是最具致癌性的基因型。在HPV DNA整合入宿主细胞基因组后,受感染细胞的永生化和转化需要两种病毒癌蛋白E6和E7的过表达。整合常常导致E2开放阅读框的缺失,相应的蛋白不再能作为p97启动子的转录抑制因子。最近,有人提出长控制区甲基化也有助于E6/E7表达的调控。为了确定哪种表观遗传机制参与HPV16早期基因调控,使用5-氮杂-2'-脱氧胞苷使Ca Ski和SiHa细胞DNA去甲基化。在两种细胞系中均观察到E6 mRNA和蛋白水平以不依赖E2的方式降低。E6的抑制既不伴随着参与长控制区调控的主要细胞转录因子表达的改变,也不伴随着E6 mRNA剪接模式的改变。相反,观察到已知会使HPV16早期病毒mRNA不稳定的miR-375明显上调。最后,使用miR-375抑制剂明确证明了miR-375参与E6的抑制。这些结果突出表明细胞DNA甲基化调节HPV16早期基因表达,并支持表观遗传事件在高危型HPV相关致癌作用中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b25/5542257/621a1b96758c/oncotarget-08-46163-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b25/5542257/fcec2422f99e/oncotarget-08-46163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b25/5542257/144755db45a3/oncotarget-08-46163-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b25/5542257/6fe59232268c/oncotarget-08-46163-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b25/5542257/5a419a9d5b41/oncotarget-08-46163-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b25/5542257/621a1b96758c/oncotarget-08-46163-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b25/5542257/fcec2422f99e/oncotarget-08-46163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b25/5542257/144755db45a3/oncotarget-08-46163-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b25/5542257/6fe59232268c/oncotarget-08-46163-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b25/5542257/5a419a9d5b41/oncotarget-08-46163-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b25/5542257/621a1b96758c/oncotarget-08-46163-g005.jpg

相似文献

1
5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression.5-氮杂胞苷(5azadC)处理可上调miR-375水平并抑制HPV16 E6表达。
Oncotarget. 2017 Jul 11;8(28):46163-46176. doi: 10.18632/oncotarget.17575.
2
HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.人乳头瘤病毒16型癌基因E6或/和E7可能影响宫颈癌细胞系HT-3中RASSFIA基因启动子区域的甲基化状态。
Oncol Rep. 2017 Apr;37(4):2324-2334. doi: 10.3892/or.2017.5465. Epub 2017 Feb 17.
3
Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.人乳头瘤病毒 E6/E7 和长非编码 RNA TMPOP2 相互上调宫颈癌细胞的基因表达。
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.01808-18. Print 2019 Apr 15.
4
Human papillomavirus type 16 E6 suppresses microRNA-23b expression in human cervical cancer cells through DNA methylation of the host gene C9orf3.人乳头瘤病毒16型E6通过宿主基因C9orf3的DNA甲基化抑制人宫颈癌细胞中的微小RNA-23b表达。
Oncotarget. 2017 Feb 14;8(7):12158-12173. doi: 10.18632/oncotarget.14555.
5
Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).人乳头瘤病毒16型癌蛋白的表达受细胞剪接因子SRSF2(SC35)调控。
J Virol. 2015 May;89(10):5276-87. doi: 10.1128/JVI.03434-14. Epub 2015 Feb 25.
6
E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.E6和E7基因沉默导致肿瘤抑制基因甲基化减少,并诱导人宫颈癌细胞系的表型转化。
Oncotarget. 2015 Sep 15;6(27):23930-43. doi: 10.18632/oncotarget.4525.
7
Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.蜜蜂毒液通过对宫颈癌细胞系中HPV E6和E7表达的差异性抑制而具有抗癌和抗病毒作用。
Oncol Rep. 2015 Apr;33(4):1675-82. doi: 10.3892/or.2015.3760. Epub 2015 Jan 28.
8
miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6.miR-2861 通过靶向 HPV16 E6 诱导的宫颈癌中的 EGFR/AKT2/CCND1 通路发挥肿瘤抑制作用。
Sci Rep. 2016 Jul 1;6:28968. doi: 10.1038/srep28968.
9
Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression.HPV16 基因和表观遗传改变对宫颈癌中 E6/E7 的表达有差异调控作用,并与疾病进展相关。
Gynecol Oncol. 2011 Dec;123(3):597-604. doi: 10.1016/j.ygyno.2011.08.004. Epub 2011 Sep 10.
10
Overexpression of HPV16 E6/E7 mediated HIF-1α upregulation of GLUT1 expression in lung cancer cells.人乳头瘤病毒16型E6/E7的过表达介导了肺癌细胞中低氧诱导因子-1α对葡萄糖转运蛋白1表达的上调。
Tumour Biol. 2016 Apr;37(4):4655-63. doi: 10.1007/s13277-015-4221-5. Epub 2015 Oct 28.

引用本文的文献

1
Epigenetic and Genetic Keys to Fight HPV-Related Cancers.对抗人乳头瘤病毒相关癌症的表观遗传和基因关键因素
Cancers (Basel). 2023 Nov 25;15(23):5583. doi: 10.3390/cancers15235583.
2
Small Molecule Inhibitors of Human Papillomavirus: A Review of Research from 1997 to 2021.小分子人乳头瘤病毒抑制剂:1997 年至 2021 年研究综述。
Curr Med Chem. 2024;31(33):5308-5350. doi: 10.2174/0929867331666230713165407.
3
The Dysregulation of MicroRNAs in the Development of Cervical Pre-Cancer-An Update.微小 RNA 在宫颈癌前病变发展中的失调——最新进展。

本文引用的文献

1
5-aza-2'-deoxycytidine (DAC) treatment downregulates the HPV E6 and E7 oncogene expression and blocks neoplastic growth of HPV-associated cancer cells.5-氮杂-2'-脱氧胞苷(DAC)处理可下调人乳头瘤病毒E6和E7癌基因的表达,并阻断人乳头瘤病毒相关癌细胞的肿瘤生长。
Oncotarget. 2016 Jul 16;8(32):52104-52117. doi: 10.18632/oncotarget.10631. eCollection 2017 Aug 8.
2
MiR-375 Is Epigenetically Downregulated by HPV-16 E6 Mediated DNMT1 Upregulation and Modulates EMT of Cervical Cancer Cells by Suppressing lncRNA MALAT1.微小RNA-375通过人乳头瘤病毒16型E6介导的DNA甲基转移酶1上调而发生表观遗传下调,并通过抑制长链非编码RNA MALAT1来调节宫颈癌细胞的上皮-间质转化。
PLoS One. 2016 Sep 22;11(9):e0163460. doi: 10.1371/journal.pone.0163460. eCollection 2016.
3
Int J Mol Sci. 2022 Jun 27;23(13):7126. doi: 10.3390/ijms23137126.
4
A Novel Cognition of Decitabine: Insights into Immunomodulation and Antiviral Effects.地西他滨的新认知:免疫调节和抗病毒作用的新见解。
Molecules. 2022 Mar 18;27(6):1973. doi: 10.3390/molecules27061973.
5
Head and Neck Cancers Are Not Alike When Tarred with the Same Brush: An Epigenetic Perspective from the Cancerization Field to Prognosis.头颈癌不能一概而论:从癌化场到预后的表观遗传学视角
Cancers (Basel). 2021 Nov 11;13(22):5630. doi: 10.3390/cancers13225630.
6
The role of HPV-induced epigenetic changes in cervical carcinogenesis (Review).人乳头瘤病毒诱导的表观遗传变化在宫颈癌发生中的作用(综述)
Biomed Rep. 2021 Jul;15(1):60. doi: 10.3892/br.2021.1436. Epub 2021 May 20.
7
Viral Manipulation of the Host Epigenome as a Driver of Virus-Induced Oncogenesis.病毒对宿主表观基因组的操控作为病毒诱导肿瘤发生的驱动因素
Microorganisms. 2021 May 30;9(6):1179. doi: 10.3390/microorganisms9061179.
8
The exon junction complex core factor eIF4A3 is a key regulator of HPV16 gene expression.外显子结合复合体核心因子 eIF4A3 是 HPV16 基因表达的关键调节因子。
Biosci Rep. 2021 Apr 30;41(4). doi: 10.1042/BSR20203488.
9
DNA demethylation agent 5azadC downregulates HPV16 E6 expression in cervical cancer cell lines independently of TBX2 expression.DNA去甲基化剂5-氮杂胞苷在不依赖TBX2表达的情况下下调宫颈癌细胞系中HPV16 E6的表达。
Oncol Lett. 2020 Jan;19(1):1074-1081. doi: 10.3892/ol.2019.11158. Epub 2019 Nov 28.
10
Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer.靶向表观遗传修饰的药物及针对结直肠癌的合理治疗策略
Front Pharmacol. 2019 Jun 6;10:588. doi: 10.3389/fphar.2019.00588. eCollection 2019.
Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer.TargomiRs的临床开发,一种基于微小RNA模拟物的复发性胸段癌症患者治疗方法。
Epigenomics. 2016 Aug;8(8):1079-85. doi: 10.2217/epi-2016-0035. Epub 2016 May 17.
4
The Functions of MicroRNAs: mRNA Decay and Translational Repression.MicroRNAs 的功能:mRNA 降解和翻译抑制。
Trends Cell Biol. 2015 Nov;25(11):651-665. doi: 10.1016/j.tcb.2015.07.011. Epub 2015 Oct 1.
5
Potential of epigenetic therapies in the management of solid tumors.表观遗传疗法在实体瘤治疗中的潜力。
Cancer Manag Res. 2015 Jul 31;7:241-51. doi: 10.2147/CMAR.S70358. eCollection 2015.
6
HPVbase--a knowledgebase of viral integrations, methylation patterns and microRNAs aberrant expression: As potential biomarkers for Human papillomaviruses mediated carcinomas.HPVbase——病毒整合、甲基化模式及微小RNA异常表达知识库:作为人乳头瘤病毒介导的癌症的潜在生物标志物。
Sci Rep. 2015 Jul 24;5:12522. doi: 10.1038/srep12522.
7
Two less common human microRNAs miR-875 and miR-3144 target a conserved site of E6 oncogene in most high-risk human papillomavirus subtypes.两种不太常见的人类微小RNA,即miR - 875和miR - 3144,靶向大多数高危型人乳头瘤病毒亚型中E6癌基因的一个保守位点。
Protein Cell. 2015 Aug;6(8):575-588. doi: 10.1007/s13238-015-0142-8. Epub 2015 Apr 28.
8
Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).人乳头瘤病毒16型癌蛋白的表达受细胞剪接因子SRSF2(SC35)调控。
J Virol. 2015 May;89(10):5276-87. doi: 10.1128/JVI.03434-14. Epub 2015 Feb 25.
9
Decitabine represses osteoclastogenesis through inhibition of RANK and NF-κB.地西他滨通过抑制RANK和NF-κB来抑制破骨细胞生成。
Cell Signal. 2015 May;27(5):969-77. doi: 10.1016/j.cellsig.2015.02.006. Epub 2015 Feb 12.
10
HPV 16 E2 binding sites 1 and 2 become more methylated than E2 binding site 4 during cervical carcinogenesis.HPV 16 E2 结合位点 1 和 2 在宫颈癌发生过程中比 E2 结合位点 4 更容易发生甲基化。
J Med Virol. 2015 Jun;87(6):1022-33. doi: 10.1002/jmv.24129. Epub 2015 Feb 3.